Home
About
Overview
Sharing Data
ORCID
Help
History (62)
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients.
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up.
DNA-utilization loci enable exogenous DNA metabolism in gut Bacteroidales.
Mobile Health for Enhanced Hypertension Self-Management in Underserved Urban Residents
See All 62 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mobile Health for Enhanced Hypertension Self-Management in Underserved Urban Residents
Overview
sponsor award id
K23HL165110
Biography
contributor
Principal Investigator
Time
start date
2023-08-01
end date
2028-07-31